Veterinary Medicines Information website

DEPO-MEDROL SUSPENSION INJECTABLE POUR CHIENS CHATS ET CHEVAUX

Authorised
  • Methylprednisolone acetate

Product identification

Medicine name:
DEPO-MEDROL SUSPENSION INJECTABLE POUR CHIENS CHATS ET CHEVAUX
Active substance:
  • Methylprednisolone acetate
Target species:
  • Dog
  • Cat
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intraarticular use

Product details

Active substance and strength:
  • Methylprednisolone acetate
    40.03
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intraarticular use
    • Horse
      • Meat and offal
        10
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB04
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pfizer Manufacturing Belgium
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2370982 7/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/09/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025